Search Results - Ivan Spicka

Refine Results
  1. 1

    Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma by Jakub Halámek, Jakub Halámek, Ivan Špička, Ivan Špička, Zdeněk Krška, Zdeněk Krška, Kristian Chrz, Kristian Chrz

    Published in Frontiers in Surgery (2026-05-01)
    Get full text
    Article


  2. 2

    Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report by Magdalena Klanova, Pavel Klener, Marek Trneny, Jan Straub, Ivan Spicka

    Published in Case Reports in Immunology (2012-01-01)
    Get full text
    Article


  3. 3

    A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemoth... by Anna Dmoszynska, Janusz Kloczko, Malgorzata Rokicka, Andrzej Hellmann, Ivan Spicka, Joseph E. Eid

    Published in Haematologica (2007-04-01)
    Get full text
    Article


  4. 4

    Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma by Heinz Ludwig, Zdenek Adam, Elena Tóthová, Roman Hajek, Boris Labar, Miklós Egyed, Ivan Spicka, Heinz Gisslinger, Johannes Drach, Ingrid Kuhn, Axel Hinke, Niklas Zojer

    Published in Haematologica (2010-09-01)
    Get full text
    Article


  5. 5

    P916: LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE (ISA-KD) IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY by Thierry Facon, Philippe Moreau, Ivan Špicka, Kenshi Suzuki, Kwee Yong, Joseph Mikhael, Taro Fukao, Kamlesh Bisht, Nicole Armstrong, Sandrine Macé, Marie-Laure Risse, Thomas Martin

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA by Tom Martin, Paul G Richardson, Thierry Facon, Philippe Moreau, Aurore Perrot, Ivan Spicka, Kamlesh Bisht, Marlene Inchauspé, France Casca, Sandrine Macé, Helgi van de Velde, Kenshi Suzuki

    Published in Haematologica (2022-06-01)
    Get full text
    Article


  7. 7

    ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VERSUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (IKEMA): FINAL OVERALL SURVIVAL ANALYSIS by Ecenur Guder Arslan, Kwee Yong, Thomas Martın, Meletios Dımopoulos, Joseph Mıkhael, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martınez, Chang-Ki Mın, Philippe Moreau

    Published in Hematology, Transfusion and Cell Therapy (2023-10-01)
    Get full text
    Article


  8. 8

    P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS by Tereza Popková, Ludek Pour, Ivan Spicka, Jakub Radocha, Alexandra Jungova, Jiri Minarik, Petr Pavlíček, Tomas Jelínek, Marta Krejčí, Jan Straub, Vladimir Maisnar, Tereza Dekojová, Tomáš Pika, Jan Soukup, Lenka Pospíšilová, Roman Hájek

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  9. 9

    Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas by Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiri Minarik, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour

    Published in Biomedicines (2022-10-01)
    Get full text
    Article


  10. 10

    Autologous stem cell transplantation for newly diagnosed multiple myeloma - real-world data from 2,149 Czech patients by Tereza Popková, Luděk Pour, Ivan Špička, Jakub Radocha, Alexandra Jungová, Jiří Minařík, Petr Pavlíček, Tomáš Jelínek, Marta Krejčí, Jan Straub, Vladimír Maisnar, Tereza Dekojová, Tomáš Pika, Jan Soukup, Lenka Pospíšilová, David Žihala, Roman Hájek

    Published in Haematologica (2026-06-01)
    Get full text
    Article


  11. 11

    Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group by Jiri Minarik, Ludek Pour, Vojtech Latal, Tomas Jelinek, Jan Straub, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Martin Stork, Tomas Pika, Petra Krhovska, Tereza Popkova, Frantisek Sedlak, Ivan Spicka, Pavel Jindra, Vladimira Capounova, Vladimir Maisnar, Roman Hajek

    Published in BMC Cancer (2025-04-01)
    Get full text
    Article


  12. 12

    Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study by Luděk Pour, Monika Szarejko, Jelena Bila, Fredrik H. Schjesvold, Ivan Spicka, Vladimir Maisnar, Artur Jurczyszyn, Zhanet Grudeva-Popova, Roman Hájek, Ganna Usenko, Marcus Thuresson, Stefan Norin, Sara Jarefors, Nicolaas A. Bakker, Paul G. Richardson, Maria-Victoria Mateos

    Published in Haematologica (2023-08-01)
    Get full text
    Article


  13. 13

    P968: ALLOCATION AND VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM IN THE ICARIA-MM AND IKEMA STUDIES by Aurore Perrot, Paul Richardson, Joseph Mikhael, Thomas G. Martin, Meral Beksac, Ivan Spicka, Marcelo Eduardo Capra, Mattia D’agostino, Pieter Sonneveld, Kamlesh Bisht, Taro Fukao, Rick Zhang, Keisuke Tada, Christina Tekle, Sandrine Macé, Zandra Klippel, Helgi van de Velde, Philippe Moreau

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  14. 14

    Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies by Paul G. Richardson, Aurore Perrot, Joseph Mikhael, Thomas Martin, Meral Beksac, Ivan Spicka, Marcelo Capra, Mattia D’Agostino, Pieter Sonneveld, Kamlesh Bisht, Taro Fukao, Rick Zhang, Keisuke Tada, Christina Tekle, Sandrine Macé, Zandra Klippel, Helgi van de Velde, Philippe Moreau

    Published in Blood Cancer Journal (2024-11-01)
    Get full text
    Article


  15. 15

    Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma by Barry Paul, Jiri Minarik, Francesca Cottini, Cristina Gasparetto, Jack Khouri, Mitul Gandhi, Jens Hillengass, Moshe Levy, Michaela Liedtke, Sudhir Manda, Irwindeep Sandhu, Douglas Sborov, Ivan Spicka, Saad Usmani, Mei Dong, Lin Gu, Carmen Leung, Parul Doshi, Christine Chen, Ludek Pour

    Published in eJHaem (2025-06-01)
    Get full text
    Article


  16. 16

    A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagn... by Jesús F. San-Miguel, Maria-Asunción Echeveste Gutierrez, Ivan Špicka, María-Victoria Mateos, Kevin Song, Michael D. Craig, Joan Bladé, Roman Hájek, Christine Chen, Alessandra Di Bacco, Jose Estevam, Neeraj Gupta, Catriona Byrne, Vickie Lu, Helgi van de Velde, Sagar Lonial

    Published in Haematologica (2018-09-01)
    Get full text
    Article


  17. 17

    P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCOMES OF LENALIDOMIDE REFRACTORY VS. LENALIDOMIDE EXPOSED RRMM PATIENTS IN THE HONEUR FEDERATED DATA NETWORK by Ivan Spicka, Ido Lapidot, Maximilian Merz, Jakub Radocha, Martin Stork, Tomas Jelínek, Alexandra Jungova, Jiri Minarik, Jan Soukup, Michel Van Speybroeck, Nolen Perualila, Joris Diels, João Duarte Mendes, Kirsten van Nimwegen, Kai Strobel, Sebastien Wischlen, Henrik Sliwka, Blanca Gros Otero, Roman Hajek

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  18. 18

    Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study by Fredrik H. Schjesvold, Heinz Ludwig, Sossana Delimpasi, Pawel Robak, Daniel Coriu, Waldemar Tomczak, Ludek Pour, Ivan Spicka, Meletios-Athanasios Dimopoulos, Tamas Masszi, Natalia G. Chernova, Anna Sandberg, Marcus Thuresson, Stefan Norin, Nicolaas A. Bakker, Maria-Victoria Mateos, Paul G. Richardson, Pieter Sonneveld

    Published in Haematologica (2024-02-01)
    Get full text
    Article


  19. 19

    Isatuximab-pomalidomide-dexamethasone <i>versus</i> pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis by Paul G. Richardson, Aurore Perrot, Jesus San Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A. Dimopoulos, Shang-Yi Huang, Jiri Minarik, Michele Cavo, H. Miles Prince, Sandrine Macé, Rick Zhang, Franck Dubin, Mony Chenda Morisse, Kenneth C. Anderson

    Published in Haematologica (2024-02-01)
    Get full text
    Article


  20. 20

    Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies by Jakub Radocha, Vladimír Maisnar, Luděk Pour, Ivan Špička, Jiři Minařík, Lenka Szeligová, Petr Pavlíček, Alexandra Jungová, Marta Krejčí, Tomáš Pika, Jan Straub, Lucie Brožová, Lukáš Stejskal, Adriana Heindorfer, Pavel Jindra, Petr Kessler, Peter Mikula, Michal Sýkora, Marek Wróbel, Jiří Jarkovský, Roman Hájek

    Published in Cancer Medicine (2018-08-01)
    Get full text
    Article


Search Tools: